2L
ATRC icon

25 LLC’s AtriCure ATRC Stock Holding History

25 LLC’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$534 – 78
2023
Q2 		$534 Buy
+10
New +$461 ﹤0.01% 484

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

25 LLC's ATRC Position: Q3 2023 in Review

25 LLC sold out of AtriCure (ATRC) in Q3 2023, closing a stake of 10 shares — an estimated $534 sold.

25 LLC first reported a position in ATRC in Q2 2023 and held it in 1 quarter. The position peaked at $534 in Q2 2023. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

  • 25 LLC reported no remaining AtriCure position as of Q3 2023 after selling out during the quarter.
  • 25 LLC sold 10 AtriCure shares in Q3 2023, an estimated $534.
  • 25 LLC first reported a position in AtriCure in Q2 2023 and held it in 1 quarter.
  • 25 LLC's AtriCure position peaked at $534 in Q2 2023.
  • 230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.